homovanillic acid and naltrexone

homovanillic acid has been researched along with naltrexone in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Moroni, F1
Devine, DP; Leone, P; Pocock, D; Wise, RA1
Funada, M; Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H; Saitoh, A; Suzuki, T1
Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T2
Kelsoe, JR; Konicki, PE; Pato, C; Pickar, D; Rapaport, MH; Wolkowitz, O1
Ahtee, L; Piepponen, TP1
de la Torre, R; Kieffer, BL; Maldonado, R; Mendizabal, V; Ortuño, J; Robledo, P1

Reviews

1 review(s) available for homovanillic acid and naltrexone

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Trials

1 trial(s) available for homovanillic acid and naltrexone

ArticleYear
Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Naltrexone; Narcotic Antagonists; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1993

Other Studies

7 other study(ies) available for homovanillic acid and naltrexone

ArticleYear
GABA turnover as a tool to explore the function of GABA-ergic synapses: physiological and pharmacological studies.
    Advances in experimental medicine and biology, 1979, Volume: 123

    Topics: Animals; Brain; Carbon Isotopes; Electric Stimulation; gamma-Aminobutyric Acid; Homovanillic Acid; Kinetics; Morphine; Naltrexone; Neurotransmitter Agents; Rats; Substantia Nigra; Synapses; Tissue Distribution

1979
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Amino Acid Sequence; Analgesics; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Male; Microinjections; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Tegmentum Mesencephali

1993
Effects of diabetes on spontaneous locomotor activity in mice.
    Neuroscience letters, 1994, Aug-29, Volume: 178, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum; Diabetes Mellitus, Experimental; Dopamine; Haloperidol; Homovanillic Acid; Male; Mice; Mice, Inbred ICR; Motor Activity; Naltrexone; Narcotic Antagonists; Prosencephalon; Receptors, Dopamine D1; Receptors, Opioid, delta; Reference Values

1994
Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice.
    Psychopharmacology, 1993, Volume: 111, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Dopamine; Homovanillic Acid; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Postural Balance; Reaction Time; Receptors, Opioid, delta

1993
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Neuropharmacology, 1993, Volume: 32, Issue:12

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward

1993
Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism.
    Pharmacology & toxicology, 1995, Volume: 77, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pain Threshold; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu

1995
The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
    The European journal of neuroscience, 2004, Volume: 20, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Avoidance Learning; Brain Chemistry; Chromatography, High Pressure Liquid; Dialysis; Dopamine; Homovanillic Acid; Mice; Mice, Inbred Strains; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Receptors, Opioid, mu; Reward; Species Specificity; Time Factors

2004